Author: Sharon LaFraniere
Pfizer Says Its Booster Is Effective Against Omicron
The company’s finding is based on only a small study of blood samples in a laboratory, but others are sure to follow.
U.S. Health Officials Project Resolve Against Omicron Variant
After the first case of an Omicron infection was detected in the U.S., the country saw the highest daily total of vaccine shots since May, though the reporting could be skewed by holiday reporting lags.
Pfizer Asks for Authorization for Boosters for Adults
An advisory panel to the Food and Drug Administration voted against a similar request from Pfizer in mid-September, but the agency is considered likely to grant the request, perhaps before Thanksgiving.
Johnson & Johnson Seeks F.D.A. Approval for Covid Booster
The company said that a second shot of its vaccine about two months after the first significantly boosts protection to 94 percent against moderate to severe disease.
F.D.A. Gives Approval for Emergent Vaccine Plant in Baltimore to Reopen
After a two-day inspection, the F.D.A. said operations could start again at the Emergent BioSolutions site where Johnson & Johnson doses were contaminated.
FDA Details Failures at Baltimore Plant That Spoiled Vaccine Doses
The F.D.A. advised Johnson & Johnson on Friday that it should throw out the equivalent of 60 million doses produced at the Baltimore plant.
F.D.A. Cites Failures at Plant Where J.&J. Doses Ruined
The Food and Drug Administration issued highly critical findings from an inspection of the plant that was forced to throw out up to 15 million doses of Johnson & Johnson’s coronavirus vaccine and ordered to temporarily stop all production.